A systematic approach to the development of a rational malaria treatment policy in Zambia

Tropical Medicine and International Health

Volumn 3, Issue 7, 1998, Pages 535-542

  Barat, Lawrence M ^a   Himonga, Benson ^b   Nkunika, Simon ^b   Ettling, Mary ^c   Ruebush, Trenton K ^a   Kapelwa, Wamibinji ^b   Bloland, Peter B ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b MINISTRY OF HEALTH   (Zambia)

^c UNITED STATES AGENCY FOR INTERNATIONAL DEVELOPMENT   (United States)

Author keywords

Chloroquine; Drug resistance; Malaria; Sulphadoxine pyremethamine; Treatment policy; Zambia

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; FANSIDAR;

CHLOROQUINE; DRUG PRESCRIBING; HEALTH POLICY; MALARIA;

ARTICLE; CHILD; CHILD HEALTH CARE; DEVELOPING COUNTRY; DRUG EFFICACY; FEMALE; HEALTH CARE POLICY; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; MALE; ORAL DRUG ADMINISTRATION; PLASMODIUM FALCIPARUM; TREATMENT OUTCOME; ZAMBIA;

ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; DRUG COMBINATIONS; DRUG EVALUATION; DRUG RESISTANCE; FEMALE; HEALTH POLICY; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; PARASITEMIA; POLICY MAKING; PYRIMETHAMINE; STATISTICS; SULFADOXINE; TIME FACTORS; ZAMBIA;

ZAMBIA;

EID: 0031830676     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.1998.00271.x     Document Type: Article

References (10)

1. Bloland PB, Lackritz EM, Kazembe PN, Were JBO, Steketee R & Campbell CC (1993) Beyond chloroquine: Implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. Journal of Infectious Diseases 167, 932-937.
2. Campbell CC (1991) Challenges Facing Antimalarial Therapy in Africa. Journal of Infectious Diseases 163, 1207-1211.
3. Centers for Disease Control and Prevention (1994) The Epi Info manual, version 6.02. Brixton Books, London.
4. Greenberg AE, Ntumbanzondo M, Ntula N, Mawa L, Howell J & Davachi F (1989) Hospital-based surveillance of malaria-related paediatric morbidity and mortality in Kinshasa, Zaire. Bulletin of the WHO 167, 189-195.
5. Khoromana CO, Campbell CC, Wirima JJ & Heymann DL (1986) In vivo efficacy of chloroquine treatment for Plasmodium falciparum in Malawian children under five years of age. American Journal of Tropical Medicine and Hygiene 35, 465-471.
6. Shah I, Rowland M, Mehmood P et al. (1997) Chloroquine resistance in Pakistan and the upsurge of falciparum malaria in Pakistani and Afgan refugee populations. Annals of Tropical Medicine and Parasitology 91, 591-602.
7. Steketee R, Macheso A, Heymann D et al. (1995) A decade of progress in malaria policy and program development in Malawi: 1984-93. USAID Document no. AOT-0483-P-HI-2171, Washington, DC.
8. World Health Organization (1973) Chemotherapy of malaria and resistance to antimalarials. Report of a WHO Scientific Group. WHO Technical Report Series 529, Geneva.
9. World Health Organization (1994) Antimalarial Drug Policies: Data requirements, treatment of uncomplicated malaria, and management of malaria in pregnancy. WHO Document no. WHO/MAL/94.1070. Geneva.
10. World Health Organization (1996) Assessment of therapeutic efficacy of antimalarial drugs: For uncomplicated falciparum malaria in areas with intense transmission. WHO Document no. WHO/MAL/96.1077.